- Home
- XENE vs CPRX Comparison
XENE vs CPRX Comparison
Compare XENE & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- CPRX
- Stock Information
- Founded
- XENE 1996
- CPRX 2002
- Country
- XENE Canada
- CPRX United States
- Employees
- XENE N/A
- CPRX N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- XENE Health Care
- CPRX Health Care
- Exchange
- XENE Nasdaq
- CPRX Nasdaq
- Market Cap
- XENE 2.9B
- CPRX 2.6B
- IPO Year
- XENE 2014
- CPRX 2006
- Fundamental
- Price
- XENE $39.04
- CPRX $21.62
- Analyst Decision
- XENE Strong Buy
- CPRX Strong Buy
- Analyst Count
- XENE 10
- CPRX 5
- Target Price
- XENE $52.90
- CPRX $33.20
- AVG Volume (30 Days)
- XENE 795.3K
- CPRX 1.1M
- Earning Date
- XENE 11-03-2025
- CPRX 11-05-2025
- Dividend Yield
- XENE N/A
- CPRX N/A
- EPS Growth
- XENE N/A
- CPRX 183.96
- EPS
- XENE N/A
- CPRX 1.65
- Revenue
- XENE $7,500,000.00
- CPRX $558,499,000.00
- Revenue This Year
- XENE N/A
- CPRX $16.59
- Revenue Next Year
- XENE $207.88
- CPRX $8.80
- P/E Ratio
- XENE N/A
- CPRX $12.95
- Revenue Growth
- XENE N/A
- CPRX 28.55
- 52 Week Low
- XENE $26.74
- CPRX $19.05
- 52 Week High
- XENE $46.00
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- XENE 41.74
- CPRX 60.02
- Support Level
- XENE $37.63
- CPRX $20.74
- Resistance Level
- XENE $42.96
- CPRX $21.74
- Average True Range (ATR)
- XENE 1.60
- CPRX 0.52
- MACD
- XENE -0.47
- CPRX 0.04
- Stochastic Oscillator
- XENE 21.42
- CPRX 91.89
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).